GlassScriptPhysician profile
Yolanda Marcos
NPI 1104845445
$12,448.97
in general payments reported to CMS, 2019-2025
72 companies · $1,862 in 2025
The $1,862 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,031 · 2020: $1,459 · 2021: $2,117 · 2022: $1,931 · 2023: $1,550 · 2024: $1,499 · 2025: $1,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,910.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,224.36 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $1,135.86 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $1,100.63 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $990.85 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $779.34 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $730.18 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $512.34 | 2019-2025 | Jardiance, Synjardy |
| Pfizer INC. | $468.82 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $404.86 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $391.74 | 2019-2024 | Austedo Xr, Austedo |
| Abbott Laboratories | $350.47 | 2019-2025 | Freestyle Libre 3, Afinion 2 |
| Allergan, INC. | $328.48 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $264.88 | 2019-2022 | |
| Esperion Therapeutics, INC. | $235.10 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $222.36 | 2020-2023 |
Show all 72 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Marcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.